...
首页> 外文期刊>Mediators of inflammation >C-Reactive Protein and Coronary Heart Disease: All Said—Is Not It?
【24h】

C-Reactive Protein and Coronary Heart Disease: All Said—Is Not It?

机译:C反应蛋白与冠心病:所有人都说,不是吗?

获取原文

摘要

C-reactive protein (CRP) and coronary heart disease (CHD) have been the subject of intensive investigations over the last decades. Epidemiological studies have shown an association between moderately elevated CRP levels and incident CHD whereas genetic studies have shown that polymorphisms associated with elevated CRP levels do not increase the risk of ischemic vascular disease, suggesting that CRP might be a bystander rather than a causal factor in the progress of atherosclerosis. Beside all those epidemiological and genetic studies, the experimental investigations also try to reveal the role of CRP in the progress of atherosclerosis. This review will highlight the complex results of genomic, epidemiological, and experimental studies on CRP and will show why further studies investigating the relationship between CRP and atherosclerosis might be needed.
机译:在过去的几十年中,C反应蛋白(CRP)和冠心病(CHD)成为了深入研究的主题。流行病学研究表明,CRP水平适度升高与冠心病的发生有关,而遗传学研究表明,与CRP水平升高相关的多态性不会增加缺血性血管疾病的风险,这表明CRP可能是患者中的旁观者而不是因果关系动脉粥样硬化的进展。除了所有这些流行病学和基因研究之外,实验研究还试图揭示CRP在动脉粥样硬化进展中的作用。这篇综述将重点介绍CRP的基因组学,流行病学和实验研究的复杂结果,并说明为什么需要进一步研究CRP和动脉粥样硬化之间关系的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号